Cerecin (Singapore Subsidiary) is VC-Backed and has raised funding across Series B and Series A rounds. It is backed by Cerecin.
Alternatives.pe tracks Cerecin (Singapore Subsidiary)'s funding history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-07-21
Browse all uploaded documents here
Extracted Financial Statement 2024
Extracted Financial Statement
ViewAudited Financial Statement 2023
Audited Financial Statement
ViewExplore the latest updates and insights
Cerecin closes Series IIB financing led by SK Securities and KNT Investment
Cerecin Inc. today announced it has raised USD $40 million
A view of the number of employees over time
Audited Financial Statement 2022
Audited Financial Statement
ViewExtracted Financial Statement 2021
Extracted Financial Statement
ViewKey members of the management team